phenylpropanolamine has been researched along with Urinary Bladder, Neurogenic in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.70) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 18 (66.67) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burckart, GJ; Green, DJ; Hirsch, M; Karesh, A; Khurana, M; Kim, MJ; Lee, J; Momper, JD; Mulugeta, Y; Sachs, HC; Yao, L | 1 |
| Eftekhar, T; Ghajarzadeh, M; Miri, E; Naeimi, M; Nikfallah, A; Teimoory, N | 1 |
| Kaur, B; Mahanta, K; Medhi, B; Narasimhan, KL | 1 |
| Honda, M; Sakakibara, R; Uchiyama, T; Watanabe, M; Yamanishi, T; Yoshida, K | 1 |
| Garely, A; Sussman, D | 1 |
| Aslan, AR; Kogan, BA | 1 |
| Pappalardo, A; Patti, F; Reggio, A | 1 |
| Bard, RJ; Casey, AR; Ethans, KD; Nance, PW; Schryvers, OI | 1 |
| Hayashi, A; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yoshino, T; Yuyama, H | 1 |
| Borgstein, NG; Ellsworth, PI; Nijman, RJ; Reddy, PP | 1 |
| Arya, M; John, J; Khan, MS; Patel, HR; Sahai, A; Singh, R | 1 |
| Aguilar, Y; Horstmann, M; Schaefer, T; Sievert, KD; Stenzl, A | 1 |
| Brubaker, L; Chapple, C; Coyne, KS; Kopp, Z | 1 |
| Leung, AK; Robson, WL | 1 |
| Christoph, F; Kempkensteffen, C; Miller, K; Moschkowitsch, A; Schostak, M; Schrader, M | 1 |
| Amend, B; Hennenlotter, J; Horstmann, M; Schäfer, T; Sievert, KD; Stenzl, A | 1 |
| Andersson, KE; Ek, A; Hedlund, H; Mattiasson, A | 1 |
| Appell, RA | 1 |
| Atan, A; Chancellor, MB; Erickson, JR; Kim, DY; Konety, BR; Yokoyama, T | 1 |
| Appell, RA; Drutz, HP; Gleason, D; Klimberg, I; Radomski, S | 1 |
| Bergé, B; Goessl, C; Michael, T; Miller, K; Sauter, T; Staehler, M | 1 |
| Albrecht, D; Anderson, R; Appell, RA; Boone, T; Dmochowski, R; Lama, D; Miklos, J; Roach, M; Saltzstein, D; Sand, P; Staskin, DR; Zinner, N | 1 |
| Anand, C; Malone-Lee, J; Powell, C; Shaffu, B | 1 |
| Rickwood, AM | 1 |
| Jonas, U; Kreder, K; Mayne, C | 1 |
| Doja, MS; Hawtrey, CE; Lin-Dyken, DC; Wolraich, ML | 1 |
| Amark, P; Beck, O | 1 |
5 review(s) available for phenylpropanolamine and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Conservative management in neurogenic bladder dysfunction.
Topics: Anti-Dyskinesia Agents; Benzhydryl Compounds; Biofeedback, Psychology; Botulinum Toxins; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Diterpenes; Electric Stimulation Therapy; Humans; Infant; Infant, Newborn; Mandelic Acids; Meningomyelocele; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Catheterization | 2002 |
[Management of neuropathic bladder in multiple sclerosis].
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxins; Capsaicin; Cresols; Diterpenes; Electric Stimulation Therapy; Humans; Multiple Sclerosis; Muscarinic Antagonists; Phenylpropanolamine; Prognosis; Quality of Life; Time Factors; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urodynamics | 2004 |
The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.
Topics: Administration, Cutaneous; Administration, Intravesical; Administration, Oral; Algorithms; Animals; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Models, Animal; Phenylpropanolamine; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence | 2006 |
Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Health Status; Humans; Mandelic Acids; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress | 2006 |
An approach to daytime wetting in children.
Topics: Arousal; Benzhydryl Compounds; Child; Child, Preschool; Constipation; Cresols; Diurnal Enuresis; Humans; Laughter; Mandelic Acids; Muscarinic Antagonists; Pelvic Floor; Phenylpropanolamine; Toilet Training; Tolterodine Tartrate; Ultrasonography; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Incontinence, Urge; Urodynamics; Vesico-Ureteral Reflux | 2006 |
15 trial(s) available for phenylpropanolamine and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Posterior tibial nerve stimulation for treating neurologic bladder in women: a randomized clinical trial.
Topics: Adult; Benzhydryl Compounds; Cresols; Electric Stimulation Therapy; Female; Humans; Middle Aged; Phenylpropanolamine; Rectum; Tibial Nerve; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive | 2014 |
Comparative efficacy and safety of extended-release and instant-release tolterodine in children with neural tube defects having cystometric abnormalities.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Neural Tube Defects; Phenylpropanolamine; Pressure; Tolterodine Tartrate; Treatment Outcome; Ultrasonography; Urinary Bladder; Urinary Bladder, Neurogenic | 2008 |
Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET).
Topics: Adult; Aged; Analysis of Variance; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urination | 2002 |
Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.
Topics: Adult; Benzhydryl Compounds; Cresols; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Multiple Sclerosis; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Spinal Cord Injuries; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Xerostomia | 2004 |
Use of tolterodine in children with neurogenic detrusor overactivity: relationship between dose and urodynamic response.
Topics: Adolescent; Area Under Curve; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Muscarinic Antagonists; Phenylpropanolamine; Safety; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Bladder, Neurogenic; Urodynamics | 2005 |
Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.
Topics: Adolescent; Adult; Benzhydryl Compounds; Benzilates; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Muscle Hypertonia; Nortropanes; Parasympatholytics; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics | 2006 |
Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.
Topics: Adolescent; Adult; Benzhydryl Compounds; Benzilates; Cresols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Spinal Cord Diseases; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urodynamics | 2008 |
Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis.
Topics: Adult; Analysis of Variance; Benzhydryl Compounds; Chi-Square Distribution; Cholinergic Antagonists; Confidence Intervals; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Statistics, Nonparametric; Time Factors; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination | 1997 |
Tolterodine for overactive bladder: time to onset of action, preferred dosage, and 9-month follow-up.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Surveys and Questionnaires; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics | 1999 |
Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination | 1999 |
Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Humans; Infant; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urodynamics | 2000 |
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nervous System Diseases; Phenylpropanolamine; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress; Urination Disorders; Xerostomia | 2001 |
Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urination | 2001 |
Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic | 2002 |
Effect of phenylpropanolamine on incontinence in children with neurogenic bladders. A double-blind crossover study.
Topics: Adolescent; Child; Double-Blind Method; Female; Humans; Male; Neural Tube Defects; Phenylpropanolamine; Urinary Bladder, Neurogenic; Urinary Incontinence; Urodynamics | 1992 |
7 other study(ies) available for phenylpropanolamine and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Drug development for pediatric neurogenic bladder dysfunction: dosing, endpoints, and study design.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Area Under Curve; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Delayed-Action Preparations; Humans; Infant; Mandelic Acids; Marine Toxins; Muscarinic Antagonists; Oxocins; Phenylpropanolamine; Quinazolines; Tablets; Tolterodine Tartrate; Urinary Bladder, Neurogenic | 2014 |
Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Prospective Studies; Quality of Life; Statistics, Nonparametric; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urodynamics | 2010 |
Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
Topics: Animals; Benzhydryl Compounds; Benzilates; Cresols; Infarction, Middle Cerebral Artery; Male; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Neurogenic | 2005 |
Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity.
Topics: Benzhydryl Compounds; Child; Cresols; Female; Follow-Up Studies; Humans; Male; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive | 2007 |
Effects of prazosin on isolated human urethra and in patients with lower motor neurons lesions.
Topics: Adolescent; Adult; Aged; Female; Humans; In Vitro Techniques; Male; Middle Aged; Motor Neurons; Norepinephrine; Phentolamine; Phenylpropanolamine; Prazosin; Quinazolines; Urethra; Urinary Bladder, Neurogenic; Urinary Incontinence | 1981 |
Assessment and conservative management of the neuropathic bladder.
Topics: Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Female; Humans; Infant; Male; Mandelic Acids; Meningomyelocele; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Catheterization | 2002 |
Follow-up of clean intermittent catheterization for children with neurogenic bladders.
Topics: Adolescent; Child; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Meningomyelocele; Parasympatholytics; Phenylpropanolamine; Self Care; Time Factors; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections; Vesico-Ureteral Reflux | 1992 |